| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-13 11:48:16 UTC |
|---|
| Update Date | 2022-03-07 02:57:14 UTC |
|---|
| HMDB ID | HMDB0041925 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Metandienone |
|---|
| Description | Methandrostenolone (trade names Averbol, Dianabol, Danabol), also known as metandienone (INN) or methandienone, is an orally-effective anabolic steroid originally developed in Germany and released in the US in the early 1960s by Ciba Specialty Chemicals. Methandrostenolone is a controlled substance in the United States and Western Europe, but remains popular among bodybuilders. Consequently, it can be found on the United States black market. However, methandrostenolone is readily available without a prescription in countries such as Mexico (under the trade name Reforvit-b), and is also being manufactured in Asia and many East European countries. |
|---|
| Structure | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C InChI=1S/C20H28O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h6,9,12,15-17,22H,4-5,7-8,10-11H2,1-3H3/t15-,16+,17+,18+,19+,20+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Methandrostenolone | Kegg | | Dianabol | Kegg | | 1, 2-Dehydro-17-methyltestosterone | HMDB | | 1,2-Dehydro-17-methyltestosterone | HMDB | | 1-Dehydro-17-alpha-methyltestosterone | HMDB | | 1-Dehydro-17-methyl-testosterone | HMDB | | 1-Dehydro-17-methyltestosterone | HMDB | | 1-Dehydro-17alpha-methyltestosterone | HMDB | | 1-Dehydromethyltestosterone | HMDB | | 17-alpha-Methyl-1-dehydrotestosterone | HMDB | | 17-alpha-Methylandrostra-1,4-dien-3-one | HMDB | | 17-beta-Hydroxy-17-alpha-methylandrostra-1,4-dien-3-one | HMDB | | 17-beta-Hydroxy-17-methyl-androsta-1,4-dien-3-one | HMDB | | 17-Hydroxy-17-methyl-(17beta)-androsta-1,4-dien-3-one | HMDB | | 17-Hydroxy-17-methyl-(17beta)-androsta-1,4-diene-3-one | HMDB | | 17-Hydroxy-17-methylandrosta-1,4-dien-3-one | HMDB | | 17-Hydroxy-17-methylandrosta-1,4-dien-3-one (acd/name 4.0) | HMDB | | 17alpha-Methyl-1-dehydrotestosterone | HMDB | | 17alpha-Methyl-androsta-1,4-dien-3-one | HMDB | | 17beta-Hydroxy-17-methyl-androsta-1,4-dien-3-one | HMDB | | 17beta-Hydroxy-17alpha-methyl-androsta-1,4-dien-3-one | HMDB | | 17beta-Hydroxy-17alpha-methylandrosta-1,4-dien-3-one | HMDB | | Abirol | HMDB | | alpha-Methyltestosterone | HMDB | | Anabolicum medivet | HMDB | | Anabolin | HMDB | | Andoredan | HMDB | | Androsta-1,4-dien-3-one, 17alpha-methyltestosterone | HMDB | | Crein | HMDB | | Danabol | HMDB | | Dehydromethyltestosterone | HMDB | | Dianabole | HMDB | | Encephan | HMDB | | Geabol | HMDB | | Laquo deltaraquo '-17-methyltestosterone | HMDB | | Laquo deltaraquo 1-17alpha-methyltestosterone | HMDB | | MA | HMDB | | Metanabol | HMDB | | Metandienon | HMDB | | Metandienonum | HMDB | | Metandrostenolon | HMDB | | Metandrostenolone | HMDB | | Metastenol | HMDB | | Methandienone | HMDB | | Methandrolone | HMDB | | Methylandrostenolone | HMDB | | Nabolin | HMDB | | Naposim | HMDB | | Nerobol | HMDB | | Nerobolettes | HMDB | | Protobolin | HMDB | | Stenolon | HMDB | | Stenolone | HMDB | | Sterolon | HMDB | | Metandienone | MeSH |
|
|---|
| Chemical Formula | C20H28O2 |
|---|
| Average Molecular Weight | 300.4351 |
|---|
| Monoisotopic Molecular Weight | 300.20893014 |
|---|
| IUPAC Name | (1S,2R,10R,11S,14S,15S)-14-hydroxy-2,14,15-trimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-3,6-dien-5-one |
|---|
| Traditional Name | methandrostenolone |
|---|
| CAS Registry Number | 72-63-9 |
|---|
| SMILES | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C |
|---|
| InChI Identifier | InChI=1S/C20H28O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h6,9,12,15-17,22H,4-5,7-8,10-11H2,1-3H3/t15-,16+,17+,18+,19+,20+/m1/s1 |
|---|
| InChI Key | XWALNWXLMVGSFR-HLXURNFRSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Androstane steroids |
|---|
| Direct Parent | Androgens and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Androgen-skeleton
- 3-oxo-delta-1,4-steroid
- 3-oxosteroid
- Hydroxysteroid
- Oxosteroid
- 17-hydroxysteroid
- Delta-1,4-steroid
- Cyclic alcohol
- Tertiary alcohol
- Ketone
- Cyclic ketone
- Organooxygen compound
- Alcohol
- Carbonyl group
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 163.5 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.17 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 18.9826 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.1 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2752.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 544.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 225.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 249.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 500.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 839.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 833.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 97.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1611.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 518.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1655.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 589.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 469.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 399.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 639.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized |
|---|